BONDANELLI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 7.065
EU - Europa 3.259
AS - Asia 1.691
SA - Sud America 29
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.048
Nazione #
US - Stati Uniti d'America 7.021
DE - Germania 1.190
CN - Cina 930
UA - Ucraina 654
IT - Italia 517
SG - Singapore 422
TR - Turchia 284
GB - Regno Unito 210
RU - Federazione Russa 189
FI - Finlandia 152
PL - Polonia 116
SE - Svezia 108
FR - Francia 56
ID - Indonesia 32
CA - Canada 24
BE - Belgio 23
BR - Brasile 17
MX - Messico 16
LT - Lituania 8
IE - Irlanda 7
IN - India 7
CZ - Repubblica Ceca 6
NL - Olanda 6
EC - Ecuador 4
IR - Iran 4
JP - Giappone 4
RO - Romania 4
DK - Danimarca 3
CL - Cile 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
VE - Venezuela 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
HN - Honduras 1
KZ - Kazakistan 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 12.048
Città #
Woodbridge 905
Chandler 722
Jacksonville 675
Fairfield 604
Ashburn 397
Houston 394
Ann Arbor 342
Santa Clara 335
Singapore 329
Wilmington 276
Seattle 211
Izmir 206
Addison 202
Nanjing 202
Beijing 192
Cambridge 183
Princeton 154
Warsaw 116
Milan 98
New York 93
San Diego 93
Shanghai 84
Shenyang 70
Boardman 66
Ferrara 58
Hebei 56
Dearborn 50
Los Angeles 48
Nanchang 46
Bremen 39
Changsha 34
Jakarta 32
Tianjin 32
Jiaxing 30
Helsinki 29
Falls Church 25
Jinan 24
Kunming 24
Redwood City 24
Brussels 23
Mountain View 23
London 22
Norwalk 21
Washington 20
Munich 17
Zhengzhou 17
Ningbo 15
San Mateo 14
Guangzhou 13
Auburn Hills 12
Bologna 12
Hefei 11
Orange 11
Rome 11
Toronto 11
Frankfurt am Main 9
Leawood 9
Taizhou 9
Modena 8
Des Moines 7
Monmouth Junction 7
Ottawa 7
Philadelphia 7
Tappahannock 7
Augusta 6
Castelnuovo Rangone 6
Changchun 6
Hangzhou 6
Indiana 6
Redmond 6
Bari 5
Dallas 5
Lanzhou 5
Verona 5
Chicago 4
Mexico 4
Pisa 4
Quito 4
Salerno 4
Treviso 4
Andover 3
Ardabil 3
Brescia 3
Caiazzo 3
Cordovado 3
Falkenstein 3
Haikou 3
Jinhua 3
Lusia 3
Montréal 3
Mumbai 3
Napoli 3
Porangatu 3
Rimini 3
Savigliano 3
Sirmione 3
Terni 3
Walnut 3
Amsterdam 2
Antwerp 2
Totale 7.961
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 240
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 157
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 148
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 144
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 143
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 139
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 134
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 131
null 130
Pituitary side effects of old and new drugs. 125
Cerebral aneurysm and acromegaly: a case report 124
Role of the serotonergic system in the genesis of vasovagal syncope. 123
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 120
In vitro testing of new somatostatin analogs on pituitary tumor cells 119
null 118
L’iperplasia surrenale congenita e la pubertà precoce 117
Acromegaly is associated with increased cancer risk: a survey in Italy 115
null 114
Growth hormone excess promotes breast cancer chemoresistance 114
null 113
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 113
null 111
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 110
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 109
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 109
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 109
null 106
null 106
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 106
Le alterazioni pressorie nell'acromegalia: fattori umorali 104
null 104
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 103
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 103
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 102
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 102
null 101
Diurnal rhythm of plasma catecholamines in acromegaly 99
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 98
null 98
Predictors of morbidity and mortality in acromegaly: An Italian survey 97
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 96
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 95
Antiproliferative effects of somatostatin analogs in pituitary adenomas 94
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 94
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 93
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 93
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 92
Prevalence of hypopituitarismin patients with cerebrovascular diseases 91
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 91
null 91
Delta opioid receptor involvement in endocrine pathophysiology 90
Glucose metabolism alterations in acromegaly 89
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 88
null 88
Cerebrovascular disease and GH-IGF-i axis function 88
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 87
Functional hypothalamic and drug-induced amenorrhea: an overview 87
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 86
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 86
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 86
Systemic illness 85
Occurrence of pituitary dysfunction following traumatic brain injury 85
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 85
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 85
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 85
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 85
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 85
Sindrome di McCune-Albright 84
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 82
Sistema Simpatoadrenomidollare nei pazienti acromegalici 82
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 81
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 81
Fisiopatologia del sistema vasopressina 80
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 80
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 80
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 80
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 78
ASSE GH-IGF-I NELL'INVECCHIAMENTO 78
Human galanin reduces plasma norepinephrine levels in man 77
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 77
INVECCHIAMENTO E GH 76
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. 76
IPOPITUITARISMO E TRAUMA CRANICO. 76
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 75
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 75
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. 74
Vecchi e nuovi analoghi della somatostatina e loro meccanismo d'azione 74
Pathogenesis and prevalence of hypertension in acromegaly 74
Replacement therapy and quality of life improvement in adult GHD patients 74
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 73
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 73
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 73
Review of Cortina criteria for the diagnosis of acromegaly 72
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 72
A new VHL polymorphism in a big family from Ferrara 72
Efficay and safety of teriparatide treatment 71
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 70
Sindrome di Von Hippel-Lindau 70
Role of GH-IGF-1 excess on periodontal tissues 70
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 70
Totale 9.658
Categoria #
all - tutte 58.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.794
Totale 66.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.247 0 0 0 0 115 249 129 210 117 261 135 31
2020/20211.368 147 104 58 169 63 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/2025967 99 76 267 106 419 0 0 0 0 0 0 0
Totale 12.214